Spots Global Cancer Trial Database for Ceramide NanoLiposome in Patients With Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Ceramide NanoLiposome in Patients With Advanced Solid Tumors
Official Title: Phase I Study of C6 Ceramide NanoLiposome in Patients With Advanced Solid Tumors
Study ID: NCT02834611
Interventions
Study Description
Brief Summary: This study is a dose escalation study of Ceramide NanoLiposome in patients with advanced solid tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland, United States
Medical University of South Carolina, Hollings Cancer Center, Charleston, South Carolina, United States
University of Virginia Cancer Center, Charlottesville, Virginia, United States
Contact Details
Name: Edward Sausville, MD, PhD
Affiliation: University of Maryland Greenebaum Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
